top of page

ÜTS Registration of Devices Under the IVDR: Class and Documents

Four classes under the IVDR, thirteen class options in ÜTS: classification rules for in vitro diagnostic devices, conformity assessment and the documents ÜTS expects.


You open ÜTS to register an immunoassay kit and try to classify it under the Medical Device Regulation. You read the rules of Annex VIII and none of them fits your kit. That is normal: the Medical Device Regulation leaves in vitro diagnostic devices outside its scope, and the classification, conformity assessment and ÜTS document set of these devices come entirely from a different regulation.

This page explains the ÜTS registration of in vitro diagnostic devices on the basis of their own legislation: which regulation applies, how the classes are determined, which class options appear on the ÜTS registration screen, which document types are requested, into which groups the document business rules fall, and where all of this departs from the registration of a device under the MDR. We do not go into the application steps of the transition period extension in detail here.

The sources are the Manual on Registration Procedures of Medical Devices in the Product Tracking System (Tıbbi Cihazların Ürün Takip Sistemine Kayıt Süreçlerine İlişkin Kılavuz) and the Medical Device Regulation (Tıbbi Cihaz Yönetmeliği) published in the Official Gazette No. 31499 (bis) of 2/6/2021.

The Medical Device Regulation does not cover in vitro diagnostic devices

The first question is which text to look at, and the answer is in the scope article of the Regulation itself. Article 1(3)(a) of the Medical Device Regulation says that the Regulation applies to all medical devices other than in vitro diagnostic devices. Article 1(4)(a) repeats the same limit from the negative side: this Regulation does not apply to in vitro diagnostic devices that fall within the scope of the In Vitro Diagnostic Medical Device Regulation (İn Vitro Tanı Amaçlı Tıbbi Cihaz Yönetmeliği) published in the Official Gazette No. 31499 (bis) of 2/6/2021.

The name of the right text appears in that point: the In Vitro Diagnostic Medical Device Regulation. Article 4(1)(ü) of the Manual defines this Regulation by the abbreviation IVDR and gives the same Official Gazette date and number. Point (şşş) of the same paragraph defines the term New Medical Device Regulations together as the Medical Device Regulation (MDR) and the In Vitro Diagnostic Medical Device Regulation (IVDR). Point (u) of the same paragraph defines the repealed Regulation on In Vitro Medical Diagnostic Devices (Vücut Dışında Kullanılan (İn Vitro) Tıbbi Tanı Cihazları Yönetmeliği) published in the Official Gazette No. 26398 of 9/1/2007 as the IVDD; this is the basis of your old documents.

One borderline case is regulated separately. Article 1(5) of the Medical Device Regulation says that a device which, when placed on the market or put into service, incorporates an in vitro diagnostic device as an integral part is subject to the provisions of this Regulation, while the provisions of the In Vitro Diagnostic Medical Device Regulation apply to the part of the device that is the in vitro diagnostic device. That is, two regulations can operate on a single product, and when registering in ÜTS you need to know which part you are registering.

The practical result is this: for an IVD device the classification rules of Annex VIII of the Medical Device Regulation, the conformity assessment annexes IX to XI, and the class names Class I to Class III are not looked at at all. All of them have separate counterparts on the IVDR side.

Four classes in the IVDR, thirteen options in ÜTS

Article 57(1) of the Manual says that devices under the IVDR are divided into four classes, Class A, Class B, Class C and Class D, in view of the risks they carry owing to their intended purpose and structure. The same paragraph adds an important explanation in parentheses: in ÜTS, additional classifications have been made according to characteristic product features and intended uses, such as whether the device is packaged sterile or whether it is, for example, a companion diagnostic device, and a device that is shown in ÜTS as, for example, a "Near-Patient Testing Device (Class C)" ("Hastabaşı Test Cihazı (Sınıf C)") is classified as Class C under the IVDR.

The full list of these additional classifications appears on the registration screen. Article 30(4)(a)(1) of the Manual says that selecting the "Class" field in ÜTS is mandatory; sub-point (3) lists the risk classes that can be selected: "Class A Sterile", "Class A", "Class B", "Class C", "Class D", "Self-Testing Device (Class B)", "Self-Testing Device (Class C)", "Self-Testing Device (Class D)", "Near-Patient Testing Device (Class B)", "Near-Patient Testing Device (Class C)", "Near-Patient Testing Device (Class D)", "Companion Diagnostic Device (Class C)" and "Companion Diagnostic Device (Class D)".

This calls for a different mindset from the structure on the MDR side. Under the MDR the risk class alone is decisive; under the IVDR the class and the manner of use are combined into a single choice. A Class C device falls into three different options in ÜTS depending on whether it is a self-testing device, a near-patient testing device or a companion diagnostic device, and a different document business rule operates accordingly.

The two concepts that define the manner of use of a device are in the definitions article of the Manual. Article 4(1)(r) of the Manual defines a near-patient testing device as an in vitro diagnostic device that is not intended for self-testing and is used so that the test is performed by a healthcare professional outside a laboratory environment, generally near or next to the patient. Point (ı) of the same paragraph defines a companion diagnostic device as a device that is essential for the safe and effective use of the relevant medicinal product, to identify, before and/or during treatment, patients who are most likely to benefit from the medicinal product or patients who are likely to be at increased risk of serious adverse reactions.

Seven classification rules and the highest-class logic

Article 57(2) of the Manual says that devices under the IVDR are classified according to a total of 7 classification rules. Compared with the twenty-two rules on the MDR side the list is short, but its scope is wide.

Point (a) of the same paragraph defines Rule 1 and gives the highest class: devices intended for detecting the presence of, or exposure to, a transmissible agent in order to assess suitability for transfusion, transplantation or cell administration; for detecting a transmissible agent that causes a life-threatening disease with a high or suspected high risk of propagation; and for determining the infective load of a life-threatening disease where monitoring is critical in the process of patient management are classified as Class D.

Point (b) of the same paragraph gives Rule 2: devices intended for blood grouping, for determining fetomaternal blood incompatibility or for tissue typing are classified as Class C; however, if these devices are intended to determine any of the markers of the ABO system, the Rhesus system, the Kell system, the Kidd system and the Duffy system, they become Class D.

Point (c) of the same paragraph lists under Rule 3 thirteen separate intended uses that fall into Class C; among them are the detection of a sexually transmitted agent, use as a companion diagnostic device, use in the screening, diagnosis or staging of cancer, human genetic testing, and the screening of newborns for congenital disorders. Point (ç) of the same paragraph classifies, under Rule 4, devices intended for self-testing as Class C; however, devices for the detection of pregnancy, fertility testing, determining the cholesterol level, and detecting glucose, erythrocytes, leucocytes and bacteria in urine are lowered to Class B. The second sub-point of the same point says that near-patient testing devices are classified in their own right.

At the lower end there are two rules. Point (d) of the same paragraph classifies, under Rule 5, the following as Class A: general culture media and histological stains, products for general laboratory use, accessories without critical characteristics, buffer solutions, washing solutions, and instruments and specimen receptacles specifically intended by the manufacturer for in vitro diagnostic procedures. Point (e) of the same paragraph puts all other in vitro diagnostic devices into Class B with Rule 6, and point (f) puts controls without a quantitative or qualitative assigned value into Class B with Rule 7.

The order of work that follows is this: first check whether the device falls under one of Rules 1 to 4, if not, check the list in Rule 5, and if it is not there either, Rule 6 comes into play. Class B is the default class in the IVDR; Class A is limited to the listed products.

Conformity assessment climbs from Class A to Class D

Article 62(2) of the Manual says that, before placing a device on the market, manufacturers carry out a conformity assessment in accordance with the relevant conformity assessment procedures set out in IVDR Annex IX to IVDR Annex XI. From here on it differs by class.

Paragraph 4 of the same article regulates Class A: except for devices intended for performance studies, manufacturers of Class A devices draw up the technical documentation as set out in IVDR Annex II and Annex III and then declare conformity by drawing up a declaration of conformity as set out in IVDR Annex IV and mentioned in Article 11 of the Manual. The same paragraph treats the sterile case separately: if the devices are placed on the market in a sterile condition, that is, if they are Class A Sterile, the manufacturer also applies one of the procedures set out in IVDR Annex IX (Chapters I and III) or in IVDR Annex XI; however, the involvement of the notified body in these procedures is limited to the aspects relating to establishing, securing and maintaining sterile conditions.

Paragraph 5 of the same article regulates Class B: manufacturers of Class B devices are subject to a conformity assessment as set out in IVDR Annex IX (Chapters I and III) and, for at least one representative device for each category of devices, to the conformity assessment procedure set out in IVDR Annex IX (Chapter II – Section 4); the Manual also gives the name of this procedure in ÜTS: Annex IX Chapter II (Excluding Section 5) Technical Documentation Assessment. The same paragraph states that, for Class B devices that are near-patient testing devices or self-testing devices, the manufacturer also follows the technical documentation assessment procedure set out in IVDR Annex IX (Chapter II – Section 5.1), that is, the Annex IX Chapter II (Including Section 5) Technical Documentation Assessment in ÜTS.

Paragraph 6(a) of the same article provides for Class C a conformity assessment including, as set out in IVDR Annex IX (Chapters I and II), a technical documentation assessment of at least one representative device for each generic device group, as set out in IVDR Annex IX (Chapter II – Section 4). Point (b) of the same paragraph adds the Annex IX (Chapter II – Section 5.1) procedure for Class C devices that are near-patient testing and self-testing devices. Paragraph 7 of the same article recognises an alternative: instead of the procedure in paragraph 6, manufacturers of Class C devices may choose to apply the conformity assessment set out in IVDR Annex X, together with the conformity assessment set out in IVDR Annex XI excluding Section 5.

Paragraph 8 of the same article regulates Class D: manufacturers of Class D devices are subject to a conformity assessment as set out in IVDR Annex IX (Chapters I and III) and in IVDR Annex IX (Chapter II (Excluding Section 5)); for Class D devices that are near-patient testing or self-testing devices, the IVDR Annex IX (Chapter II Section 5.1) procedure is added. Paragraph 9 of the same article gives an alternative here too: manufacturers of Class D devices may choose to apply a conformity assessment as set out in IVDR Annex X, together with a conformity assessment as set out in IVDR Annex XI.

The difference between Class A and the others is clear in these paragraphs. In Class A, in the non-sterile condition, the notified body is not involved; from Class B onwards every device goes through a notified body process. This is the IVDR counterpart of the Class-I distinction in the MDR, but the boundary sits much lower: under the MDR Class-I is numerically a wide group, while under the IVDR Class A is limited to the listed product types.

Companion diagnostic and Class D devices have additional consultation steps

One side of the IVDR that has no counterpart in the MDR is the involvement of medicines authorities and reference laboratories in conformity assessment. Article 62(6)(c) of the Manual says that, for Class C devices that are companion diagnostic devices, in addition to the procedures in points (a) and (b) of the same paragraph the notified body follows, for each device, the technical documentation assessment procedure set out in IVDR Annex IX (Chapter II – Section 5.2), and under this procedure consults the Agency and/or one of the competent authorities designated by EU member states in the field of medicinal products for human use, or the EMA. Paragraph 8 of the same article repeats the same consultation obligation for Class D devices that are companion diagnostic devices, and paragraph 9 for Class D companion diagnostic devices that choose the Annex X route.

In Class D there is also laboratory verification. Paragraph 10 of the same article says that the notified body carrying out the conformity assessment, particularly for devices for which one or more EU reference laboratories have been designated, requests laboratory testing to verify the performance claimed by the manufacturer and the compliance of the device with the applicable common specifications, as set out in point 4.9 of IVDR Annex IX or point (h) of Section 3 of Annex X. The same paragraph states that these tests focus in particular on analytical and diagnostic sensitivity, using the best available reference materials.

Paragraph 11 of the same article defines one more additional step: where common specifications are not available for Class D devices and it is also the first certification for this type of device, the notified body consults the relevant experts of the expert panels established by the Commission on the manufacturer's performance evaluation report, and submits the report to the expert panel within 5 days of receiving it.

The counterpart of these steps in ÜTS is not a field as such, but it determines the content of the certificate set. The certificate that reaches you for a Class C companion diagnostic product carries different annexes from an ordinary Class C certificate, and all of them must be uploaded.

The document types ÜTS expects in IVD registrations

The document types are shared between the MDR and the IVDR; ÜTS does not define a separate "IVD certificate" type. Article 7(1) of the Manual says that the document of the "EU Certificate (MDR/IVDR)" ("AB Sertifikası (MDR/IVDR)") type is used only for certificates issued by a notified body under the New Medical Device Regulations; this type covers both MDR and IVDR certificates. Article 11(1) of the Manual builds the same structure for the "EU Declaration of Conformity (MDR/IVDR)" ("AB Uygunluk Beyanı (MDR/IVDR)") type.

The list of documents to be linked is written in a separate article for the IVDR. Article 67(1) of the Manual says that, for a device registration notification under the IVDR, according to the type and risk class of the device, the appropriate one or ones of the documents that are in "Registered" status in ÜTS as a result of an application made under Article 39 of the Manual and are mentioned in Articles 7, 11, 17, 20, 22, 23 and 24 of the Manual must be linked to the device. In that order these are the EU certificate, the EU declaration of conformity, the instructions for use, the quality management document, the domestic goods certificate, the authorised distributorship certificate and the catalogue.

There is also an IVDR-specific provision in the content of the declaration. Article 11(2)(ı) of the Manual looks for the name and identification number of the notified body and the identification of the EU certificate or certificates issued, in EU declarations of conformity other than those whose scope consists only of Class-I Other or Class A devices. On the IVDR side this exemption is only for Class A devices; a Class A Sterile device is outside this exemption.

On the authorised representative side as well, the basis is the IVDR. Sub-point (1) of Article 11(2)(b) of the Manual states that, under Article 11(1) of the MDR and Article 12(1) of the IVDR, manufacturer firms established outside the EU member states and Turkey are obliged to appoint an authorised representative.

The document business rules fall into seven separate groups in the IVDR

Article 67(2) of the Manual says that the linking is carried out in ÜTS according to the document business rules determined by the type and risk class of the device and on the basis of the conformity assessment procedures mentioned in Article 62 of the Manual. The same article then lists the groups one by one.

Paragraph 3 of the same article says that, for devices to be notified for registration as "Class A" or "Class A Sterile", the appropriate one of the business rules shown in Annex-94 is applied; paragraph 4 points to Annex-95 for "Class B" or "Class C"; and paragraph 5 points to Annex-96 for "Class D". The groups that differ by manner of use are tied to separate annexes: paragraph 6 of the same article points to Annex-97 for "Self-Testing Device (Class B)" or "Near-Patient Testing Device (Class B)"; paragraph 7 to Annex-98 for "Self-Testing Device (Class C)" or "Self-Testing Device (Class D)"; paragraph 8 to Annex-99 for "Near-Patient Testing Device (Class C)" or "Near-Patient Testing Device (Class D)"; and paragraph 9 to Annex-100 for "Companion Diagnostic Device (Class C)" or "Companion Diagnostic Device (Class D)".

In registration practice this distribution means that four different sets of business rules can operate for your Class C product in ÜTS, and the choice you make in the "Class" field decides which one operates. Selecting "Class C" in the Class field without stating that the device is in fact a near-patient testing device leads you to proceed with the wrong document set.

The link on the registration screen is clear as well. Article 30(5)(a)(2) of the Manual says that the documents to be added in line with the appropriate one of the document business rules mentioned in Article 67 of the Manual, according to the risk class of the device, are selected from among the documents already registered in ÜTS as a result of an application made under Article 39 of the Manual. Sub-point (3) of the same point makes it mandatory that the class of the device has been selected before the documents are selected.

The Basic UDI-DI is tied to the same order. Article 30(5)(c)(3) of the Manual states that, before a selection is made from the "Select Basic UDI-DI" ("Temel UDI-DI Seç") screen, it is mandatory to select from the "Documents" field the documents associated with the device and its Basic UDI-DI under the business rule in Article 67 of the Manual, that is, the EU Declaration of Conformity and the EU Certificate. Sub-point (4) of the same point says that more than one selection cannot be made in this field.

Where the instructions for use are mandatory and where optional under the IVDR

The obligation concerning instructions for use is clearly separated on the IVD side by class and manner of use. Article 17(2)(b) of the Manual says that uploading the instructions for use issued by the manufacturer is mandatory for Class B, Class C and Class D devices certified under the IVDR, and for Self-Testing Devices (Class B/C/D), Near-Patient Testing Devices (Class B/C/D) and Companion Diagnostic Devices (Class C/D).

Paragraph 3 of the same article gives the exemption: uploading instructions for use is optional for device groups in the other risk group, that is, Class-I Other, Class-Im, Class-Is, Class-Ir, Class A, Class A Sterile and IVD Other devices. Class A and Class A Sterile are in this list; under the IVDR the instructions-for-use obligation starts from Class B.

IVDs under the old regulation are in the same article. Point (c) of the same paragraph says that uploading the instructions for use issued by the manufacturer is mandatory for devices under Annex-II List-A or Annex-II List-B certified under the IVDD and for Self-Testing Devices.

In the case of accessories, IVDs do not benefit from the Class-IIa exemption of the MDR. Article 17(5) of the Manual says that, for Class B, Class C and Class D devices, Self-Testing Devices (Class B/C/D), Near-Patient Testing Devices (Class B/C/D) and Companion Diagnostic Devices (Class C/D) under the IVDR, and for Annex-II List-A and Annex-II List-B devices and Self-Testing Devices under the IVDD, where the manufacturer of the main device is different from the manufacturer of the accessory, the accessory's own instructions for use, or if there are none, the instructions for use created by the manufacturer of the main device, are uploaded without regard to criteria such as differences in notified body and address.

IVDR-specific fields on the registration screen

Article 30(1) of the Manual says that, during device registration under the IVDR, the information on the ÜTS registration screen is found under the headings "Identifying Information" ("Tanımlayıcı Bilgiler"), "Import/Manufacture Information" ("İthal/İmal Bilgileri"), "Classification Information" ("Sınıflandırma Bilgileri"), "Product Documents" ("Ürün Belgeleri"), "Product Images" ("Ürün Görselleri"), "Features" ("Özellikler"), "Dimension Information" ("Ölçü Bilgileri"), "Storage/Use Condition Information" ("Saklama/kullanım Koşulu Bilgileri"), "CMR and/or Endocrine Disrupting Substance Information" ("CMR ve/veya Endokrin Bozucu Madde Bilgileri") and "Application Status" ("Başvuru Durumu"). The heading structure is the same as on the MDR screen; the differences are inside the fields.

On the classification information side, two coding fields come next to the class field. Article 30(4)(b)(1) of the Manual says that selecting the GMDN field is mandatory, sub-point (2) says that each device has only one GMDN code, and sub-point (3) says that if the GMDN code that identifies the device appears in at least one of the documents of the device, the code stated in that document is selected. Sub-point (1) of point (c) of the same paragraph states that selecting the branch type code field is also mandatory.

The EMDN field is a conditional field. Article 30(4)(ç)(1) of the Manual says that, until a new decision is taken by the Agency on the matter, and if the EMDN code that identifies the device does not appear in at least one of the documents of the device, selecting the EMDN term field in ÜTS is optional. Sub-point (5) of the same point sets the opposite rule: if the EMDN code appears in at least one of the documents, such as the EU certificate or the EU declaration of conformity, selecting the most detailed code and terminal term of the EMDN code stated in that document is mandatory. Sub-point (4) of the same point states that each device has only one EMDN code.

There is a consistency requirement on the barcode side as well. Article 30(2)(b)(4) of the Manual says that a device application made under Article 40 of the Manual for a device record whose barcode is not entered into the system as it appears in its technical documents, that is, in documents such as the label, the sales packaging, the EU declaration of conformity and the EU certificate, will have a negative outcome.

IVDD documents and the 26/5/2022 threshold

If your document is under the IVDD, a separate document type and a separate set of business rules come into play. Article 65(1) of the Manual says that, for a device registration notification under the IVDD, the appropriate one of the documents mentioned in Articles 6, 10, 17, 20, 22, 23 and 24 of the Manual is linked to the device; that is, an EC certificate is used instead of an EU certificate, and a declaration of conformity instead of an EU declaration of conformity. Paragraph 2 of the same article ties the linking to the conformity assessment procedures in Article 60 of the Manual.

Paragraph 3 of the same article points to Annex-85 for devices to be notified for registration as "IVD Other" or "Annex-2 List-A"; paragraph 4 to Annex-86 for "Annex-2 List-B"; and paragraph 5 to Annex-87 for "Self-Testing Devices". The class names on the IVDD side have nothing in common with those of the IVDR; ÜTS keeps them as separate options.

The date threshold directly decides whether a declaration is acceptable. Article 10(9) of the Manual says that, under Article 107 and Article 108(1)(d) of the IVDR, the IVDD was repealed as of 26/5/2022, and that devices under the IVDD that were legally placed on the market before this date may continue to be made available on the market or put into service only with a declaration of conformity issued before 26/5/2022. The same paragraph expressly states that the first issue date of a declaration of conformity issued for devices under the IVDD must be before 26/5/2022.

The same paragraph allows a limited update: provided that the devices benefit from the IVDR transitional provisions mentioned in Article 48 of the Manual, the declaration may be updated for changes other than "significant changes" in the product scope of the declaration and in the design and intended purpose of the devices, such as a change of manufacturer address, a change of manufacturing site, a change of EU authorised representative and a change of GMDN code. The same paragraph states that the updated declaration is expected to be linked to its version before 26/5/2022, and that if the link cannot be established, the old version must be uploaded to the "Technical Document of the Product(s) in the Document" ("Belgedeki Ürün(ler)e Ait Teknik Doküman") field.

Benefiting from the transition period requires a separate application

Staying on the market with an IVDD document does not happen automatically in ÜTS. Article 48(3) of the Manual says that, provided that the conditions set out in the relevant Regulation are met, devices placed on the market under the IVDD as Annex-2 List-A, Annex-2 List-B and Self-Testing Devices may be made available on the market or put into service until 31.12.2027.

Paragraph 4 of the same article gives three separate dates for devices for which the conformity assessment procedure under the IVDD did not require the involvement of a notified body, for which a declaration of conformity was drawn up before 26 May 2022, and which under the IVDR require the involvement of a notified body. Point (a) of the same paragraph gives 31.12.2027 for devices to be classified under the IVDR as Class D, Self-Testing Device (Class D), Near-Patient Testing Device (Class D) and Companion Diagnostic Device (Class D); point (b) gives 31.12.2028 for Class C and the related self-testing, near-patient testing and companion diagnostic devices; and point (c) gives 31.12.2029 for devices to be classified as Class B, Near-Patient Testing Device (Class B) and Class A Sterile.

Paragraph 5 of the same article describes the path to follow: for firms to be able to benefit from the IVDR transitional provisions for their devices under these paragraphs, they must first apply through EBS under Article 49 of the Manual, and if the application is found suitable by the Agency, they must make the device and/or document registration or update applications in ÜTS for the relevant devices and their linked documents under Article 50 of the Manual.

The application type of this application in ÜTS is different too. Article 39(8) of the Manual says that, in the document applications mentioned in Articles 47 and 50 of the Manual, the type "Document Application under Notice No. 2023/KK-1" ("2023/KK-1 Sayılı Duyuru Kapsamında Belge Başvurusu"), stated in point (ç) of paragraph 4 of the same article, is selected as the "Application Type". A transition period application and an ordinary IVD document application are not made in ÜTS on the same screen with the same type.

What we do in IVD registration, and what we cannot do

Within medical device ÜTS registration consultancy, our concrete outputs on the IVD side are these:

  • Scope determination: We determine, within the framework of Article 1(3), (4) and (5) of the Medical Device Regulation, whether the product is an in vitro diagnostic device and whether it contains an integral IVD part, and we record in writing which regulation applies.

  • Class and ÜTS option mapping: We give reasons for which of the seven rules in Article 57(2) of the Manual operates, and map this to one of the thirteen ÜTS options in Article 30(4)(a) of the Manual.

  • Document set check: We determine which of paragraphs 3 to 9 of Article 67 of the Manual operates, and report before the application any gap in the documents that business rule looks for.

  • Declaration and certificate link: We check that, in all IVD declarations other than Class A, the notified body and certificate number information is present, as required by Article 11(2)(ı) of the Manual.

  • Coding: We fill in the GMDN, branch type and EMDN fields according to the points of Article 30(4) of the Manual, and if a code is not defined in ÜTS, we prepare the addition request through "Report Request" ("Talep Bildir").

  • Transition timetable: Based on the dates in paragraphs 3 and 4 of Article 48 of the Manual, we work out which device is at which threshold and plan the order of applications required.

What we cannot do is clear as well. We cannot determine the class of a device; classification rests on the manufacturer's statement of intended purpose, and the conformity assessment procedure in Article 62 of the Manual is carried out by the manufacturer. We cannot produce the performance evaluation, the analytical and clinical performance data or the technical documentation in place of the manufacturer. The reference laboratory verification and the expert panel consultation foreseen in paragraphs 10 and 11 of Article 62 of the Manual for companion diagnostic and Class D devices are steps carried out by the notified body; we cannot intervene in these steps. Nor do we give any commitment on the outcome of the Agency's review.

Our way of working is as follows: the firm defines a user authorisation for us from its own ÜTS firm page, and we create the IVD document and device records with the "Medical Device Registration Operator" ("Tıbbi Cihaz Kayıt Elemanı") authorisation; the person who electronically signs the document and device applications remains the firm's signatory.

Tıbbi Cihaz ÜTS Kayıt Danışmanlığı

Request an ÜTS registration consultancy quote

Ehlibeyt Mahallesi, Tekstilciler Caddesi No: 35/7 06520 Çankaya / Ankara - TÜRKİYE

Cevizli Mahallesi, Zuhal Caddesi Ritim İstanbul B Blok, No:44 Maltepe / İstanbul - TÜRKİYE

info@medexmedikal.com
+90 505 580 4622
+90 312 389 1354

ÜTS Guides · Legislation Calendar · Glossary · ÜTS Guide Index · Frequently Asked Questions

Services: ÜTS Consultancy · Who Carries Out the ÜTS Registration? · ÜTS Document Registration Consultancy · ÜTS Product Registration Consultancy · Importer ÜTS Registration Consultancy · Sales Centre Authorisation Certificate · EUDAMED Registration Consultancy · MDR/IVDR Declaration of Conformity · Technical File Preliminary Review · Label and Instructions for Use Check · PRRC Service · PMS and PSUR · Clinical Evaluation · EMDN and GMDN Code Determination · Certificate of Free Sale · EUDAMED XML Generator · ÜTS Registration Training · Correction of a Rejected ÜTS Application

KVKK and Privacy Policy | Cookie Policy | Accessibility Statement

© 2026 Medex Kurumsal Danışmanlık Ltd. Şti.

bottom of page
WhatsApp Hemen Ara